Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury

Key facts

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Principal Investigator

Limin Rong, M.D.

Sun Yat-sen University

Intervention

Umbilical Cord Mesenchymal Stem Cells(drug)

Enrollment

84 target

Eligibility

18-65 years · All sexes

Timeline

2019 – 2021

Study locations (1)

• Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Collaborators

West China Hospital · Shanghai East Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Spinal cord injury

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1, PHASE2NCT06410001
  CE-STAND: Cervical Epidural STimulation After Neurologic Damage
  University of Minnesota
• RECRUITINGNANCT07204184
  Multisite Transspinal Stimulation for Augmenting Recovery in Spinal Cord Injury
  Maria Knikou, PT, MBA, PhD
• RECRUITINGNANCT06924177
  UTSW NORC Pilot Spinal Cord Injury Dietary Program
  University of Texas Southwestern Medical Center
• RECRUITINGNANCT06867809
  Spine and Brain Stimulation for Movement Recovery After Cervical Spinal Cord Injury
  Jason Carmel
• ENROLLING BY INVITATIONNANCT06873776
  Arm and Leg Cycling for Accelerated SCI Recovery
  Shirley Ryan AbilityLab
• RECRUITINGNANCT07135583
  Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
  Thomas Jefferson University
• RECRUITINGNANCT07222033
  Self-balancing Personal Exoskeleton for SCI (WINY)
  Wandercraft
• RECRUITINGPHASE1, PHASE2NCT06677229
  Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury
  Technophage, SA

See all trials for Spinal cord injury →